HR 2905
Medicare IVIG Access Enhancement Act
Take action
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Bill overview
This bill, the Medicare IVIG Access Enhancement Act, aims to test whether Medicare coverage and payment for intravenous immune globulin (IVIG) administered at home can improve access for people with chronic inflammatory demyelinating polyneuropathy or multifocal motor neuropathy. It proposes a three-year demonstration project where up to 3,000 Medicare beneficiaries can voluntarily receive IVIG at home, with payment determined based on a national low-utilization payment amount, adjusted to account for the specific needs of this patient population. The project’s results will be evaluated and reported to Congress to determine if broader changes to Medicare coverage are warranted.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Earl Blumenauer
Cosponsors
David E. Price
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.